The Forum Presents:ย
DRUG TRIALS -- Challenges for Alzheimerโs and Other Urgent Needs
Watch the live webcast on our website on Friday, April 15, 2016, Noon-1pm ET EVENT DESCRIPTION:
This Forum will explore the challenges and complexities of drug trials, and how they impact disease treatment and prevention โ particularly for conditions that currently have little or no therapeutic options. As a case study, the panel will discuss Alzheimerโs and several drugs in development for that disease, but also address broader concerns related to the pharmaceutical testing pipeline for unmet medical needs as a whole. Additional priority areas will be discussed including other neurodegenerative diseases, bacterial infections, and antibiotic resistance. An expert panel will explore pharmaceutical priorities and the time and cost of R&D; alternative pathways for expediting drug development; barriers and solutions to trial recruitment and retention; and gender and racial disparities in clinical trial results. As the complexities and costs of clinical trials grow, the discussion will explore policy recommendations that can help to create a sustainable and effective drug development system for unmet and urgent disease threats worldwide. This event is presented in partnership with HHMI Tangled Bank Studios, in collaboration with STAT, and in association with NOVA. โโโโโโโโโโโโโโโโโโโโโโโโโโโโ- ENGAGE WITH US: Send our panelists questions in advance to [email protected] Weโll be conducting a live chat on The Forum website during the live webcast. Tweet us @ForumHSPH #drugtrials
RSVP to our Facebook event, share on your wall, and invite your friends. Watch the live webcast on our website on Friday, April 15, 2016, Noon-1pm ET โโโโโโโโโโโโโโโโโโโโโโโโโโโโ- EXPERT PARTICIPANTS: Reisa Sperling Professor of Neurology, Harvard Medical School, and Director of the Center for Alzheimerโs Research and Treatment and of the Clinical Research, Memory Disorders Unit, Brigham and Womenโs Hospital James Ware Professor of Biostatistics and Associate Dean for Clinical and Translational Science, Harvard T.H. Chan School of Public Health, and statistical consultant to The New England Journal of Medicine Aaron Kesselheim Associate Professor of Medicine at Harvard Medical School, and Director, Program on Regulation, Therapeutics, and Law, Brigham and Womenโs Hospital Pamela Tenaerts Executive Director of the Clinical Trials Transformation Initiative Jill Goldstein Professor of Psychiatry and Medicine at Harvard Medical School and Director of Research at the Connors Center for Womenโs Health and Gender Biology and Brigham and Womenโs Hospital Moderated by Sharon Begley, Senior Science Writer, STAT โโโโโโโโโโโโโโโโโโโโโโโโโโโโ- ADDITIONAL INFORMATION: Forum viewers may want to tune into the NOVA film โCan Alzheimerโs Be Stopped?โ, which premieres Wednesday, April 13, 2016, at 9pm ET/8C on PBS. Part of: Policy Controversies Presented in partnership with HHMI Tangled Bank Studios, in collaboration with STAT, and in association with NOVA Image Credit: Jellyfish Pictures
